Shanghai, China

Jian Ding

This inventor holds 58 USPTO granted patents and 15 published patent applications and 30 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Chinese Academy of Sciences, Green Valley (Shanghai) Pharmaceuticals Co., Ltd., Shanghai Haihe Pharmaceutical Co., Ltd.. Active years: 2001-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Ding. Retrieved from https://idiyas.com/inventor/jian-ding-xxu1qqfw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 58 

% Patents Active = 74.1

 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 51(Granted Patents)

Forward Citations (Not Self Cited) = 42(Dec 10, 2025)


Company Filing History:

goldMedal43 out of 3,364 
 
Chinese Academy of Sciences
 patents
silverMedal8 out of 8 
 
Green Valley (Shanghai) Pharmaceuticals Co., Ltd.
 patents
bronzeMedal6 out of 9 
 
Shanghai Haihe Pharmaceutical Co., Ltd.
 patents
4. 3 out of 3 
 
Shanghai Flowdynamics Medical Technology Co., Ltd.
 patents
5. 3 out of 13 
 
Shanghai Fochon Pharmaceutical Co., Ltd.
 patents
6. 2 out of 117 
 
Shanghai Research Institute of Petrochemical Technology, Sinopec
 patents
7. 1 out of 368 
 
Adir Et Compagnie
 patents
8. 1 out of 95 
 
China Petroleum & Chemical Corporation
 patents
9. 1 out of 674 
 
China Petroleum Chemical Corporation
 patents
10. 1 out of 37 
 
China Pharmaceutical University
 patents
11. 1 out of 3 
 
Chongqing Fochon Pharmaceutical Co., Ltd.
 patents
12. 1 out of 7 
 
Cisen Pharmaceutical Co., Ltd.
 patents
13. 1 out of 552 
 
Dalian University of Technology
 patents
14. 1 out of 73 
 
East China Normal University
 patents
15. 1 out of 139 
 
East China University of Science and Technology
 patents
16. 1 out of 1 
 
Fukang (Shanghai) Health Technology Co., Ltd.
 patent
17. 1 out of 1 
 
Haihe Biopharma Co., Ltd.
 patent
18. 1 out of 2 
 
Nanjing Luyesike Pharmaceutical Co., Ltd.
 patents
19. 1 out of 1 
 
Shanghai Acebright Pharmaceuticals Co., Ltd.
 patent
20. 1 out of 5 
 
Shanghai Green Valley Pharmaceutical Co., Ltd.
 patents
21. 1 out of 1 
 
Shanghai Institute of Materia Medica, Chinese Acad
 patent
22. 1 out of 1 
 
Shanghai Pharmaceutical (Group) Co., Ltd.
 patent
23. 1 out of 2 
 
Shanghai Puyi Chemical Co., Ltd.
 patents
24. 1 out of 1 
 
Shanghai Runshi Medical Technology Co., Ltd
 patent
25. 4 out of 834,601 
Other
 patents
where one patent can have more than one assignee

Years Active: 2001-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
CSF-1R Kinase Inhibitor
Algal Proteoglycan Extract
Mannuronic Diacid
Indazole Compounds
Pyrimidine Compounds
Triazolopiperazine PARP Inhibitor
Substituted Pyrazolecarboxamides
Optical Isomers
Fused-Cyclic Pyrazolone
Polysaccharide Degradation
Light Aromatics Catalyst
ERK Kinase Inhibitory Activity
58 patents (USPTO):Explore Patents

Title: Jian Ding: A Shanghai-Based Innovator Driving Pharmaceutical Advancements

Introduction:

In the fast-paced world of pharmaceutical research and development, innovators like Jian Ding play a crucial role in advancing medical science. Hailing from Shanghai, China, Ding has made significant contributions to the field through his numerous patents and established career in esteemed organizations. This article delves into the latest patents of Jian Ding, highlights key milestones in his career, and explores his fruitful collaborations with talented colleagues.

Latest Patents:

Jian Ding boasts an impressive number of 46 patents, showcasing his commitment to pushing boundaries and finding novel solutions to critical health challenges. Let's explore two of his most recent patents:

1. Substituted amino six-membered nitric heterocyclic ring compound and preparation and use thereof:

This patent presents a substituted amino six-membered nitric heterocyclic ring compound and its preparation and use. The compound, represented by general formula (I), demonstrates exceptional tyrosine kinase inhibitory activity. As a result, it holds enormous potential in the development of medicines for treating diseases associated with tyrosine kinase inhibitory activity.

2. Indolizine compounds, preparation method and use thereof:

Ding's second recent patent encompasses indolizine compounds and their preparation method and use. These compounds, including those represented by formula I or a pharmaceutically acceptable salt, exhibit inhibitory effects on EZH2 or EZH1, both wild-type and/or mutant. This innovation opens doors for the development of novel anti-tumor drugs and treatments for autoimmune diseases.

Career Highlights:

Throughout his career, Jian Ding has contributed significantly to the advancements in pharmaceutical research. He has held positions in esteemed institutions such as the Shanghai Institute of Materia Medica, Chinese Academy of Sciences, and Green Valley Pharmaceuticals Co., Ltd. Let's take a closer look at his notable career milestones:

1. Shanghai Institute of Materia Medica:

Ding's journey began at the prestigious Shanghai Institute of Materia Medica, where he honed his skills and expertise in medicinal chemistry. His contributions to groundbreaking research projects greatly influenced the development of new and effective pharmaceutical interventions.

2. Chinese Academy of Sciences:

With a strong foundation established, Ding proceeded to make substantial contributions at the Chinese Academy of Sciences. His innovative ideas and meticulous research helped propel advancements in drug discovery and development, earning him recognition within the scientific community.

3. Green Valley Pharmaceuticals Co., Ltd.:

Ding's expertise and dedication to pharmaceutical innovation led him to the esteemed Green Valley Pharmaceuticals. In this role, he contributed to the company's mission of developing cutting-edge medicines and therapeutic solutions, solidifying his position as a healthcare pioneer.

Collaborations:

Jian Ding's journey has been enriched by his collaborations with talented colleagues. Among notable associates are Meiyu Geng and Yi Chen. Geng, known for her expertise in synthetic organic chemistry, has collaborated closely with Ding on various projects, amplifying their impact in the field. Similarly, Ding's partnership with Yi Chen, a skilled medicinal chemist, has resulted in significant breakthroughs in drug discovery and development. These fruitful collaborations have facilitated knowledge exchange and allowed for the seamless integration of diverse skill sets.

Conclusion:

Jian Ding, an accomplished innovator based in Shanghai, has demonstrated tremendous dedication and expertise in the pharmaceutical realm. With an impressive patent count of 46, his contributions in the field of medicinal chemistry and drug development are invaluable. Ding's vast experience, successful career in esteemed organizations, and fruitful collaborations highlight his profound impact on advancing medical science. As an ardent contributor to the ever-evolving landscape of healthcare, Jian Ding continues to drive innovation, ultimately benefiting patients worldwide.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…